Cases & Deals

  • Home
  • Practices
  • Cellectis establishes at-the-market (ATM) program for up to US$125 million on Nasdaq

Share

Cellectis establishes at-the-market (ATM) program for up to US$125 million on Nasdaq

March 2021

Client(s) Cellectis SA

Jones Day assisted Cellectis SA in connection with the implementation of an at-the-market (ATM) program for up to US$125 million on Nasdaq and the subsequent first draw down of US$47 million under the program. Cellectis is the second company in France to have implemented an ATM program.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.